Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
AbstractBackground. Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2020
|
| In: |
Neuro-Oncology
Year: 2019, Volume: 22, Issue: 5, Pages: 613-624 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noz235 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noz235 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noz235/5691191 |
| Author Notes: | Ben Ho, Pascal D. Johann, Yura Grabovska, Mamy Jean De Dieu Andrianteranagna, Fupan Yao, Michael Frühwald, Martin Hasselblatt, Franck Bourdeaut, Daniel Williamson, Annie Huang, and Marcel Kool |
| Summary: | AbstractBackground. Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the |
|---|---|
| Item Description: | Advance access date 31 December 2019 Gesehen am 21.04.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noz235 |